Perplexity AI Predicts Whether Moderna Stock Can Make Investors Rich in 2026

A single trial readout just doubled a company’s market value in one session. Perplexity AI predicts the rerating continues, and the price prediction places Moderna at $180 to $240 by the end of 2026 with a $210 bullish base case.The catalyst is Intismeran, the personalized mRNA cancer vaccine. Perplexity calls it the dominant valuation driver […]

The post Perplexity AI Predicts Whether Moderna Stock Can Make Investors Rich in 2026 appeared first on Cryptonews.

Leave a Reply

Your email address will not be published. Required fields are marked *

UP NEXT

Related Tags

Loading RSS Feed

You May Like

Subscribe To Our Newsletter

Metus in ac vivamus dui id purus in risus. Nunc fringilla donec amet pulvinar vivamus suscipit. Augue porttitor eu sed proin tortor bibendum facilisis felis. Nunc egestas tellus nisl tempor aliquet malesuada ali eu sed proin tortor bibendum facilisis felis
Stay Updated by our Monthly / Weekly News Update. Zero Spamming. Terms & Condition Applied